BridgeMD
New treatment option for Lung Cancer (Diagnosis)
Official title Acupressure for Cough in Lung Cancer Survivors
ClinicalTrials.gov ID: NCT07315672
What this study is testing
- What it's testing
- The goal of this randomized controlled trial is to examine the effect of an acupressure intervention in alleviating cough and reducing co-occurring symptoms (dyspnea, cough, and fatigue) in patients with lung cancer. The hypotheses are: 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- be at least 18 years of age;
- have a diagnosis of LC at any stage and of any pathological type;
- have a cough symptom rating ≥3 on a 0 to 10 numeric rating scale within 7 days preceding enrollment;
- can perform acupressure independently in daily activities;
- be able to read Chinese and communicate in Cantonese or Mandarin;
You likely can't join if
- have unstable chronic diseases other than LC;
- have received acupressure or acupuncture within the three months preceding study enrollment;
- have serious illnesses or other conditions that prevent the participants from following the intervention protocols;
- have a life expectancy of less than 3 months;
- Be currently participating in other research programs that may affect the outcomes under investigation.
See the full eligibility criteria
- be at least 18 years of age;
- have a diagnosis of LC at any stage and of any pathological type;
- have a cough symptom rating ≥3 on a 0 to 10 numeric rating scale within 7 days preceding enrollment;
- can perform acupressure independently in daily activities;
- be able to read Chinese and communicate in Cantonese or Mandarin;
- be able to provide informed consent.
- have unstable chronic diseases other than LC;
- have received acupressure or acupuncture within the three months preceding study enrollment;
- have serious illnesses or other conditions that prevent the participants from following the intervention protocols;
- have a life expectancy of less than 3 months;
- Be currently participating in other research programs that may affect the outcomes under investigation.
The study team makes the final eligibility decision.
Where it's taking place
- Shenzhen, Guangdong, China
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenzhen, Guangdong, China; Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.